[Correction of immune disorders with neoselenium in patients with chronic bronchitis]
- PMID: 12698851
[Correction of immune disorders with neoselenium in patients with chronic bronchitis]
Abstract
The examination covered 55 patients with chronic bronchitis (mean age 58 +/- 4.2 years, mean duration of the disease 11.2 +/- 5.2 years). All the patients were in remission and received broncholytics. In 32 of them, basic treatment was combined with a course of immunorehabilitation with neoselenium. The effect of the latter was assessed at immunological examination of the patients before and after the treatment with indirect immunofluorescence with monoclonal antibodies. Neoselenium appeared to have an immunomodulating action on all immunity links, it enhanced functional activity and bactericidity of antigen-presenting cells and cytotoxic activity of natural killers, diminished the tension in the function of endogenic antioxidant systems.
Similar articles
-
[Experience of ribomunyl application in patients with chronic bronchitis].Klin Med (Mosk). 2005;83(12):53-7. Klin Med (Mosk). 2005. PMID: 16502726 Russian.
-
Modulation of natural killer cell activity in patients with immune-inflammatory diseases.Dan Med Bull. 1988 Aug;35(4):315-22. Dan Med Bull. 1988. PMID: 2458887 Review. No abstract available.
-
[Possibilities of immunomodulation in patients with chronic bronchitis during physiotherapeutic impacts on the thymic area].Vopr Kurortol Fizioter Lech Fiz Kult. 2004 Jul-Aug;(4):14-6. Vopr Kurortol Fizioter Lech Fiz Kult. 2004. PMID: 15449665 Russian.
-
The role of natural killer T (NKT) cells in immune thrombocytopenia: is strong in vitro NKT cell activity related to the development of remission?Br J Haematol. 2005 May;129(4):564-5. doi: 10.1111/j.1365-2141.2005.05495.x. Br J Haematol. 2005. PMID: 15877744 No abstract available.
-
Impaired NK cell function in ESRD patients.Blood Purif. 2008;26(4):315-6. doi: 10.1159/000130067. Epub 2008 May 8. Blood Purif. 2008. PMID: 18463432 Review. No abstract available.
Cited by
-
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2. Cochrane Database Syst Rev. 2022. PMID: 36373977 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical